Allogeneic human mesenchymal stem cells (hMSCs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic human mesenchymal stem cells (hMSCs), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)